WHO ICTRP trial
A multicenter randomized double-blind study on the sensitization of advanced…
ITMCTR2025001231 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Recruiting
Key facts
| Trial ID | ITMCTR2025001231 |
|---|---|
| Public title | A multicenter randomized double-blind study on the sensitization of advanced non-small cell lung cancer by Yanghe Tang combined with chemotherapy based on the theory of "Yang deficiency and toxin accumulation": regulation of PARP1/T cell metabolic axis |
| Scientific title | Yanghe decoction combined with chemotherapy sensitizes advanced non-small cell lung cancer: A multicenter randomized double-blind study on the regulation of PARP1/T cell metabolic axis |
| Primary sponsor | Gansu University of Chinese Medicine |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | Others |
| Countries | CHINA |
| Conditions | Advanced non-small cell lung cancer |
| Interventions | Combined group (Yanghe decoction +TP regimen chemotherapy):Patients in the combination group started taking Yanghe Tang 7 days before chemotherapy and continued until the end of chemotherapy. Yanghe Tang is decocted according to… |
| Registration date | Jun 21, 2025 |
| Target size | Combined group (Yanghe decoction +TP regimen chemotherapy):81;Control group… |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: